Current Medical Research and Opinion

Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study
pp. 1-10(10)
Authors: Li, Huafang; Ma, Cui; Wang, Gang; Zhu, Xiaotong; Peng, Mengye; Gu, Niufan

Improving glycemic control with insulin detemir using the 303 Algorithm in insulin naïve patients with type 2 diabetes: a subgroup analysis of the US PREDICTIVE 303 study
pp. 11-20(10)
Authors: Selam, Jean-Louis; Koenen, Christoph; Weng, Wayne; Meneghini, Luigi

Switching from other antipsychotics to once-daily extended release quetiapine fumarate in patients with schizophrenia
pp. 21-32(12)
Authors: Ganesan, S.; Agambaram, V.; Randeree, F.; Eggens, I.; Huizar, K.; Meulien, D.; Study 147 Investigators,

Multiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers
pp. 33-40(8)
Authors: Krishnan, Suma M.; Stark, Jeffrey G.

Pancreatic β-cell function as a predictor of cardiovascular outcomes and costs: findings from the Cardiovascular Health Study
pp. 41-50(10)
Authors: Curtis, Lesley H.; Hammill, Bradley G.; Bethel, M. Angelyn; Anstrom, Kevin J.; Liao, Lawrence; Gottdiener, John S.; Schulman, Kevin A.

Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands
pp. 51-61(11)
Authors: Hoogendoorn, Martine; Welsing, Paco; Rutten-van Mölken, Maureen P.M.H.

Economic evaluation of treatment with orlistat in Italian obese patients
pp. 63-74(12)
Authors: Iannazzo, S.; Zaniolo, O.; Pradelli, L.

C-reactive protein (CRP): more than just an innocent bystander?
pp. 75-78(4)
Authors: Paraskevas, Kosmas I.; Mikhailidis, Dimitri P.

Effect of pramlintide as an adjunct to basal insulin on markers of cardiovascular risk in patients with type 2 diabetes
pp. 79-85(7)
Authors: Wysham, Carol; Lush, Cameron; Zhang, Bei; Maier, Holly; Wilhelm, Ken

Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty
pp. 87-97(11)
Authors: Friedman, Richard J.; Gallus, Alexander S.; Cushner, Fred D.; Fitzgerald, Gordon; Anderson, Frederick A.; The Global Orthopaedic Registry Investigators,

Vitamin D inadequacy in postmenopausal women in Eastern Asia
pp. 99-106(8)
Authors: Lim, S.K.; Kung, A.W.C.; Sompongse, S.; Soontrapa, S.; Tsai, K.S.

Non-vertebral fracture risk reduction with oral bisphosphonates: challenges with interpreting clinical trial data
pp. 107-119(13)
Author: Miller, Paul D.

The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke
pp. 121-127(7)
Authors: Breekveldt-Postma, Nancy S.; Penning-van Beest, Fernie J.A.; Siiskonen, Satu J.; Falvey, Heather; Vincze, Gábor; Klungel, Olaf H.; Herings, Ron M.C.

Treatment and costs associated with anemic chronic kidney disease patients
pp. 129-137(9)
Authors: Rasu, Rafia S.; Crawford, Tonya; Manley, Harold; Balkrishnan, Rajesh

Molecular basis of the potential of vitamin D to prevent cancer
pp. 139-149(11)
Authors: Ingraham, Betty A.; Bragdon, Beth; Nohe, Anja

Use of 2-octyl cyanoacrylate for skin closure of sternal incisions in cardiac surgery: observations of microbial barrier effects
pp. 151-155(5)
Authors: Souza, E.C.; Fitaroni, R.B.; Januzelli, D.M.; Macruz, H.M.S.; Camacho, J.C.A.; Souza, M.R.C.

A systematic review of the effectiveness of rivastigmine for the treatment of behavioral disturbances in dementia and other neurological disorders
pp. 157-166(10)
Authors: Figiel, Gary; Sadowsky, Carl

The impact of esophageal candidiasis on hospital charges and costs across patient subgroups
pp. 167-174(8)
Authors: Tong, Kuo B.; Murtagh, Kirsten N.; Lau, Christopher; Seifeldin, Raafat

Oxycodone: a review of its use in the management of pain
pp. 175-192(18)
Authors: Riley, Julia; Eisenberg, Elon; Müller-Schwefe, Gerhard; Drewes, Asbjørn M.; Arendt-Nielsen, Lars

Utility of health states in chronic kidney disease: a structured review of the literature
pp. 193-206(14)
Authors: Dale, P.L.; Hutton, J.; Elgazzar, H.

Once-monthly oral ibandronate compared with weekly oral alendronate in postmenopausal osteoporosis: results from the head-to-head MOTION study
pp. 207-213(7)
Authors: Miller, Paul D.; Epstein, Sol; Sedarati, Farhad; Reginster, Jean-Yves

Decreasing the incidence and impact of infections in neutropenic patients: evidence from meta-analyses of randomized controlled trials
pp. 215-235(21)
Authors: Falagas, Matthew E.; Vardakas, Konstantinos Z.; Samonis, George

Ibandronate and the risk of non-vertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta-analysis of phase III studies
pp. 237-245(9)
Authors: Harris, Steven T.; Blumentals, William A.; Miller, Paul D.

Addendum
pp. 247-247(1)

Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia
pp. 249-259(11)
Authors: Assmann, Gerd; Kannenberg, Frank; Ramey, Dena R.; Musliner, Thomas A.; Gutkin, Stephen W.; Veltri, Enrico P.

Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study
pp. 261-266(6)
Authors: Berto, Patrizia; Frati, Franco; Incorvaia, Cristoforo; Cadario, Gianni; Contiguglia, Rosario; Di Gioacchino, Mario; Puccinelli, Paola; Senna, Gian Enrico; Valle, Carla

Clopidogrel versus aspirin in patients with atherothrombosis: CAPRIE-based calculation of cost-effectiveness for Germany
pp. 267-274(8)
Authors: Berger, K.; Hessel, F.; Kreuzer, J.; Smala, A.; Diener, H.C.

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
pp. 275-286(12)
Authors: Klonoff, David C.; Buse, John B.; Nielsen, Loretta L.; Guan, Xuesong; Bowlus, Christopher L.; Holcombe, John H.; Wintle, Matthew E.; Maggs, David G.

Comparison of the safety and efficacy of loteprednol 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of blepharokeratoconjunctivitis
pp. 287-296(10)
Authors: White, Eric M.; Macy, Jonathan I.; Bateman, Kirk M.; Comstock, Timothy L.

Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence of alcohol
pp. 297-305(9)
Authors: Sathyan, G.; Sivakumar, K.; Thipphawong, J.

An international survey of sleeping problems in the general population
pp. 307-317(11)
Authors: Léger, D.; Poursain, B.; Neubauer, D.; Uchiyama, M.